Target Discovery For Anticancer Therapy Facilitated By Artificial Intelligence

Target Discovery for Anticancer Therapy Facilitated by Artificial Intelligence

Artificial Intelligence in the Age of Nanotechnology

In the world of academia, scholars and researchers are confronted with a rapidly expanding knowledge base in Artificial Intelligence (AI) and nanotechnology. The integration of these two groundbreaking fields presents an intricate web of concepts, innovations, and interdisciplinary applications that can overwhelm even the most astute academic minds. Staying up to date with the latest developments and effectively navigating this complex terrain has become a pressing challenge for those striving to contribute meaningfully to these fields. Artificial Intelligence in the Age of Nanotechnology is a transformative solution meticulously crafted to address the academic community's knowledge gaps and challenges. This comprehensive book serves as the guiding light for scholars, researchers, and students grappling with the dynamic synergy between AI and Nanotechnology. It offers a structured and authoritative exploration of the core principles and transformative applications of these domains across diverse fields. By providing clarity and depth, it empowers academics to stay at the forefront of innovation and make informed contributions.

Targeted Cancer Therapy in Biomedical Engineering

This book highlights the role of Biomedical Engineering (BME) used in diagnosis (e.g., body scanners) and treatment (radiation therapy and minimal access surgery in order to prevent various diseases). In recent years, an important progress has been made in the expansion of biomedical microdevices which has a major role in diagnosis and therapy of cancer. When fighting cancer, efficacy and speed are of the utmost importance. A recently developed microfluidic chip has enabled a breakthrough in testing the efficacy of specialized cancer drugs. Effective cancer-targeting therapies will require both passive and active targeting strategies and a thorough understanding of physiologic barriers to targeted drug delivery. Targeted cancer treatments in development and the new combinatorial approaches show promise for improving targeted anticancer drug delivery and improving treatment outcomes. This book discusses the advancements and innovations in the field of BME that improve the diagnosis and treatment of cancer. This book is focused on bioengineering approaches to improve targeted delivery for cancer therapeutics, which include particles, targeting moieties, and stimuli-responsive drug release mechanisms. This book is a useful resource for students, researchers, and professionals in BME and medicine.